| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 66 |
| 1 | SORAFENIB | 46 |
| 2 | OLANZAPINE | 42 |
| 3 | DUPILUMAB | 36 |
| 4 | LEVETIRACETAM | 36 |
| 5 | FUROSEMIDE | 34 |
| 6 | REGORAFENIB | 31 |
| 7 | PANTOPRAZOLE | 30 |
| 8 | METFORMIN | 29 |
| 9 | PIMAVANSERIN TARTRATE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FEXINIDAZOLE | 1 | 0.0769 |
| 1 | SODIUM SULFACETAMIDE 10%, SULFUR 5% | 1 | 0.0714 |
| 2 | SODIUM SULFACETAMIDE 9.8% SULFUR 4.8% | 1 | 0.0667 |
| 3 | SODIUM SULFACETAMIDE, SULFUR | 1 | 0.0476 |
| 4 | SODIUM SULFACETAMIDE AND SULFUR | 1 | 0.0476 |
| 5 | SULFACETAMIDE SODIUM AND SULFUR | 1 | 0.0417 |
| 6 | SULFACETAMIDE SODIUM, SULFUR | 1 | 0.0087 |
| 7 | MOISTURIZER | 1 | 0.0083 |
| 8 | SERTACONAZOLE NITRATE | 1 | 0.0062 |
| 9 | FENFLURAMINE | 17 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 110 |
| 1 | Benzodiazepine [EPC] | 72 |
| 2 | Kinase Inhibitor [EPC] | 65 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 65 |
| 4 | Corticosteroid [EPC] | 43 |
| 5 | Anti-epileptic Agent [EPC] | 38 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 36 |
| 7 | Loop Diuretic [EPC] | 35 |
| 8 | Mood Stabilizer [EPC] | 35 |
| 9 | Osmotic Laxative [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 5 | 0.0026 |
| 1 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 7 | 0.0014 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 10 | 0.0013 |
| 4 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 5 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 6 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 7 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 8 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 9 | Cholinesterase Inhibitor [EPC] | 17 | 0.0009 |